Hubbell Strickland Wealth Management LLC acquired a new stake in Carmell Co. (NASDAQ:CTCX – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 12,548 shares of the company’s stock, valued at approximately $32,000. Hubbell Strickland Wealth Management LLC owned 0.07% of Carmell as of its most recent filing with the Securities and Exchange Commission.
Separately, Linden Advisors LP purchased a new position in Carmell during the third quarter worth about $270,000. Institutional investors own 24.22% of the company’s stock.
Carmell Price Performance
CTCX traded up $0.31 during trading on Monday, reaching $1.64. The company’s stock had a trading volume of 33,075 shares, compared to its average volume of 9,066. The company’s fifty day moving average price is $2.10 and its 200-day moving average price is $2.79. Carmell Co. has a 52-week low of $1.11 and a 52-week high of $13.31.
About Carmell
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Further Reading
- Five stocks we like better than Carmell
- Low PE Growth Stocks: Unlocking Investment Opportunities
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How to Evaluate a Stock Before BuyingÂ
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Consumer Staples Stocks, Explained
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.